Discovery of the Potent and Selective Inhaled Janus Kinase 1 Inhibitor AZD4604 and Its Preclinical Characterization

被引：6

作者：

Nilsson, Magnus ^{[1
]}

Berggren, Kristina ^{[1
]}

Berglund, Susanne ^{[1
]}

Cerboni, Silvia ^{[2
]}

Collins, Mia ^{[2
]}

Dahl, Goran ^{[3
]}

Elmqvist, David ^{[4
]}

Grimster, Neil P. ^{[5
]}

Hendrickx, Ramon ^{[6
]}

Johansson, Johan R. ^{[1
]}

Kettle, Jason G. ^{[5
]}

Lepisto, Matti ^{[1
]}

Rhedin, Magdalena ^{[2
]}

Smailagic, Amir ^{[2
]}

Su, Qibin ^{[5
]}

Wennberg, Tiiu ^{[2
]}

Wu, Allan ^{[7
]}

Osterlund, Torben ^{[8
]}

Naessens, Thomas ^{[2
]}

Mitra, Suman ^{[2
]}

机构：

[1] AstraZeneca, BioPharmaceut R&D, Resp & Immunol, Med Chem Res & Early Dev, SE-43183 Gothenburg, Sweden

[2] AstraZeneca, BioPharmaceut R&D, Resp & Immunol, Biosci Res & Early Dev, SE-43183 Gothenburg, Sweden

[3] AstraZeneca, BioPharmaceut R&D, Struct & Biophys Res & Early Dev, Discovery Sci, SE-43183 Gothenburg, Sweden

[4] AstraZeneca, BioPharmaceut R&D, Pharmaceut Sci, Early Prod Dev, SE-43183 Gothenburg, Sweden

[5] AstraZeneca R&D, Oncol R&D, Waltham, MA 02451 USA

[6] AstraZeneca, BioPharmaceut R&D, Res & Early Dev, Resp & Immunol,DMPK, SE-43183 Gothenburg, Sweden

[7] AstraZeneca R&D, Discovery Sci, R&D, Waltham, MA 02451 USA

[8] AstraZeneca, BioPharmaceut R&D, Res & Early Dev, Discovery Sci,Mechanist Biol & Profiling, SE-43183 Gothenburg, Sweden

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2023年

关键词：

T-CELLS; TISSUE DISTRIBUTION; JAK1; INHIBITORS; IMMUNITY; IDENTIFICATION; MECHANISMS;

D O I：

10.1021/acs.jmedchem.3c00554

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

JAK-STAT cytokines are critical in regulating immunity. Persistent activation of JAK-STAT signaling pathways by cytokines drives chronic inflammatory diseases such as asthma. Herein, we report on the discovery of a highly JAK1-selective, ATP-competitive series of inhibitors having a 1000-fold selectivity over other JAK family members and the approach used to identify compounds suitable for inhaled administration. Ultimately, compound 16 was selected as the clinical candidate, and upon dry powder inhalation, we could demonstrate a high local concentration in the lung as well as low plasma concentrations, suggesting no systemic JAK1 target engagement. Compound 16 has progressed into clinical trials. Using 16, we found JAK1 inhibition to be more efficacious than JAK3 inhibition in IL-4-driven Th2 asthma.

引用

页码：13400 / 13415

页数：16

共 50 条

[21] Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation [J].

Furet, Pascal ;

Guagnano, Vito ;

Fairhurst, Robin A. ;

Imbach-Weese, Patricia ;

Bruce, Ian ;

Knapp, Mark ;

Fritsch, Christine ;

Blasco, Francesca ;

Blanz, Joachim ;

Aichholz, Reiner ;

Hamon, Jacques ;

Fabbro, Doriano ;

Caravatti, Giorgio .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (13) :3741-3748

[22] Discovery and Characterization of a Selective Inhibitor of Synaptojanin1 5-Phosphatase Activity [J].

Martin, Ella ;

Giakoumakis, Danae ;

Paesmans, Jone ;

Bisi, Nicolo ;

Drozdzecki, Andrzej ;

Audenaert, Dominique ;

Haustraete, Jurgen ;

Verstreken, Patrik ;

Galicia, Christian ;

Ballet, Steven ;

Versees, Wim .

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2025,

[23] Discovery of Selective and Potent ATR Degrader for Exploration its Kinase-Independent Functions in Acute Myeloid Leukemia Cells [J].

Wang, Yubo ;

Wang, Ruonan ;

Zhao, Yanli ;

Cao, Sheng ;

Li, Chen ;

Wu, Yanjie ;

Ma, Lan ;

Liu, Ying ;

Yao, Yuhong ;

Jiao, Yue ;

Chen, Yukun ;

Liu, Shuangwei ;

Zhang, Kun ;

Wei, Mingming ;

Yang, Cheng ;

Yang, Guang .

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2024, 63 (17)

[24] Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signaling [J].

Zak, Mark ;

Hanan, Emily J. ;

Lupardus, Patrick ;

Brown, David G. ;

Robinson, Colin ;

Siu, Michael ;

Lyssikatos, Joseph P. ;

Romero, F. Anthony ;

Zhao, Guiling ;

Kellar, Terry ;

Mendonca, Rohan ;

Ray, Nicholas C. ;

Goodacre, Simon C. ;

Crackett, Peter H. ;

McLean, Neville ;

Hurley, Christopher A. ;

Yuen, Po-wai ;

Cheng, Yun-Xing ;

Liu, Xiongcai ;

Liimatta, Marya ;

Kohli, Pawan Bir ;

Nonomiya, Jim ;

Salmon, Gary ;

Buckley, Gerry ;

Lloyd, Julia ;

Gibbons, Paul ;

Ghilardi, Nico ;

Kenny, Jane R. ;

Johnson, Adam .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (12) :1522-1531

[25] Discovery and Preclinical Characterization of BIIB129, a Covalent, Selective, and Brain-Penetrant BTK Inhibitor for the Treatment of Multiple Sclerosis [J].

Himmelbauer, Martin K. ;

Bajrami, Bekim ;

Basile, Rebecca ;

Capacci, Andrew ;

Chen, Teyu ;

Choi, Colin K. ;

Gilfillan, Rab ;

de Turiso, Felix Gonzalez-Lopez ;

Gu, Chungang ;

Hoemberger, Marc ;

Johnson, Douglas S. ;

Jones, J. Howard ;

Kadakia, Ekta ;

Kirkland, Melissa ;

Lin, Edward Y. ;

Liu, Ying ;

Ma, Bin ;

Magee, Tom ;

Mantena, Srinivasa ;

Marx, Isaac E. ;

Metrick, Claire M. ;

Mingueneau, Michael ;

Murugan, Paramasivam ;

Muste, Cathy A. ;

Nadella, Prasad ;

Nevalainen, Marta ;

Parker Harp, Chelsea R. ;

Pattaropong, Vatee ;

Pietrasiewicz, Alicia ;

Prince, Robin J. ;

Purgett, Thomas J. ;

Santoro, Joseph C. ;

Schulz, Jurgen ;

Sciabola, Simone ;

Tang, Hao ;

Vandeveer, H. George ;

Wang, Ti ;

Yousaf, Zain ;

Helal, Christopher J. ;

Hopkins, Brian T. .

JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (10) :8122-8140

[26] Preclinical Characterization of the Selective JAK1 Inhibitor LW402 for Treatment of Rheumatoid Arthritis [J].

Zhang, Ning ;

Zhang, Changqing ;

Zeng, Zhihong ;

Zhang, Jiyong ;

Du, Shengnan ;

Bao, Chunde ;

Wang, Zhe .

JOURNAL OF INFLAMMATION RESEARCH, 2021, 14 :2133-2147

[27] Preclinical Characterization of GLPG0634, a Selective Inhibitor of JAK1, for the Treatment of Inflammatory Diseases [J].

Van Rompaey, Luc ;

Galien, Rene ;

van der Aar, Ellen M. ;

Clement-Lacroix, Philippe ;

Nelles, Luc ;

Smets, Bart ;

Lepescheux, Lien ;

Christophe, Thierry ;

Conrath, Katja ;

Vandeghinste, Nick ;

Vayssiere, Beatrice ;

De Vos, Steve ;

Fletcher, Stephen ;

Brys, Reginald ;

van 't Klooster, Gerben ;

Feyen, Jean H. M. ;

Menet, Christel .

JOURNAL OF IMMUNOLOGY, 2013, 191 (07) :3568-3577

[28] Discovery of (2R)-N-[3-[2-[(3-Methoxy-1-methyl-pyrazol-4-yl)amino]pyrimidin-4-yl]-1H-indol-7-yl]-2-(4-methylpiperazin-1-yl)propenamide (AZD4205) as a Potent and Selective Janus Kinase 1 Inhibitor [J].

Su, Qibin ;

Banks, Erica ;

Bebernitz, Geraldine ;

Bell, Kirsten ;

Borenstein, Cassandra F. ;

Chen, Huawei ;

Chuaqui, Claudio E. ;

Deng, Nanhua ;

Ferguson, Andrew D. ;

Kawatkar, Sameer ;

Grimster, Neil P. ;

Ruston, Linette ;

Lyne, Paul D. ;

Read, Jon A. ;

Peng, Xianyou ;

Pei, Xiaohui ;

Fawell, Stephen ;

Tang, Zhanlei ;

Throner, Scott ;

Vasbinder, Melissa M. ;

Wang, Haoyu ;

Winter-Holt, Jon ;

Woessner, Richard ;

Wu, Allan ;

Yang, Wenzhan ;

Zinda, Michael ;

Kettle, Jason G. .

JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (09) :4517-4527

[29] Discovery of potent, selective, and orally bioavailable inhibitors of interleukin-1 receptor-associate kinase-4 [J].

Wang, Zhulun ;

Sun, Daqing ;

Johnstone, Sheree ;

Cao, Zhaodan ;

Gao, Xiong ;

Jaen, Juan C. ;

Liu, Jingqian ;

Lively, Sarah ;

Miao, Shichang ;

Sudom, Athena ;

Tomooka, Craig ;

Walker, Nigel P. C. ;

Wright, Matthew ;

Yan, Xuelei ;

Ye, Qiuping ;

Powers, Jay P. .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (23) :5546-5550

[30] Structure-based discovery of IHMT-IDH1-053 as a potent irreversible IDH1 mutant selective inhibitor [J].

Liang, Qianmao ;

Wang, Beilei ;

Zou, Fengming ;

Guo, Gongrui ;

Wang, Wenliang ;

Wang, Wei ;

Liu, Qingwang ;

Shen, Lijuan ;

Hu, Chen ;

Wang, Wenchao ;

Wang, Aoli ;

Huang, Tao ;

He, Yuying ;

Xia, Ruixiang ;

Ge, Jian ;

Liu, Jing ;

Liu, Qingsong .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 256

← 1 2 3 4 5 →